Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Flow Chemistry Asia 2022

Giancarlo Pascali's Biography



Giancarlo Pascali, Professor, University of New South Wales

Dr. Giancarlo Pascali has worked in the field of radiopharmaceutical sciences for over 20 years, since his studies in Chemistry at the University of Pisa. He obtained his PhD working at the IFC-CNR in Pisa (Italy) and at NIH (MD, USA). He has then worked in several institutions; among them, he has been Key Scientist for the FP7 project “Radiochemistry On Chip” and QC manager for GMP production plant. He moved in Australia in 2013 as Radiochemistry Team Leader at the ANSTO cyclotron; following his interest in aligning research and clinical activities, he is currently Principal Hospital Scientist at the Prince of Wales Hospital, and Conjoint Associate Professor at the School of Chemistry of UNSW. Giancarlo is an internationally renowned leader in radiopharmaceutical sciences, in particular for the research and development on new tracers, radiochemical methods and automation strategies. His activities are focused on the use of cyclotron-produced nuclides, but extend also to reactor and generator produced ones, as well as on-demand synthetic chemistry. He is one of the pioneers in the use of microfluidics approaches in radiochemistry.

Giancarlo Pascali Image

Microfluidics and Flow Chemistry In Radiochemistry: A Perfect (Future) Match?

Friday, 7 October 2022 at 09:30

Add to Calendar ▼2022-10-07 09:30:002022-10-07 10:30:00Europe/LondonMicrofluidics and Flow Chemistry In Radiochemistry: A Perfect (Future) Match?Flow Chemistry Asia 2022 in Tokyo, JapanTokyo, JapanSELECTBIOenquiries@selectbiosciences.com

The use of microfluidic systems and flow chemistry was pioneered in radiochemistry in 2004; since then, numerous researchers have shown how using these techniques can provide a much better yield, economy, reliability and safety. This talk will give several examples demonstrating how the unique features of these approaches are a perfect match with the numerous challenges of radiochemistry. However, currently only a small number of commercial synthetic systems adopt these concepts; the last part of this talk will be aimed at proposing some causes for this surprising fact, potentially stimulating useful synergies with the traditional pharmaceutical manufacturing actors.


Add to Calendar ▼2022-10-06 00:00:002022-10-07 00:00:00Europe/LondonFlow Chemistry Asia 2022Flow Chemistry Asia 2022 in Tokyo, JapanTokyo, JapanSELECTBIOenquiries@selectbiosciences.com